| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 01/21/2010 | WO2009103741A3 Use of fsh receptor ligands for diagnosis and therapy of cancer |
| 01/21/2010 | WO2009067767A3 Targeted radiotherapy |
| 01/21/2010 | US20100015167 in vitro method of screening an individual for metastatic colorectal cancer cells or primary and/or metastatic stomach or esophageal cancer cells; vaccine comprising a protein that comprises human sucrase isomaltase protein |
| 01/21/2010 | US20100015152 Diagnostic and therapeutic methods |
| 01/21/2010 | US20100015053 Radiolabelled trp m8 receptor ligands |
| 01/21/2010 | US20100015052 Stabilisation of radiopharmaceutical precursors |
| 01/21/2010 | US20100015051 Transferrin-conjugated nanoparticles for increasing efficacy of a therapeutic agent |
| 01/21/2010 | US20100015050 Peg and targeting ligands on nanoparticle surface |
| 01/21/2010 | US20100015049 Methods and compositions for treating postoperative pain comprising nonsteroidal anti-inflammatory agents |
| 01/21/2010 | US20100015048 Internalizing Anti-CD74 Antibodies and Methods of Use |
| 01/21/2010 | US20100015047 Lung-Expressed Polypeptides |
| 01/21/2010 | US20100015046 Camptothecin-Binding Moiety Conjugates |
| 01/21/2010 | US20100015045 Cancerous Disease Modifying Antibodies |
| 01/21/2010 | US20100015044 Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases |
| 01/21/2010 | US20100015043 Cytochrome c acetylation |
| 01/21/2010 | US20100015042 Combine radiation therapy and chemotherapy for treating cancer |
| 01/21/2010 | US20100015041 Class of Supramolecular Drug Molecules and Methods of Identification and Use Thereof |
| 01/21/2010 | CA2731134A1 Novel method for measuring insulin resistance |
| 01/21/2010 | CA2731053A1 A compound for imaging cell death |
| 01/21/2010 | CA2730973A1 Radiolabelled trp m8 receptor ligands |
| 01/20/2010 | EP2144912A1 18 f-labelled folates |
| 01/20/2010 | EP2144633A2 A system for delivering therapeutic agents into living cells and cells nuclei |
| 01/20/2010 | CN101628121A Method for marking nano-hydroapatite particles by radioactive nuclide <125>I |
| 01/20/2010 | CN100581589C Radioactively labelled amino acid analogues, their preparation and use |
| 01/19/2010 | US7649080 Reacting vancomycin with a coupling reagent, then reacting with a cephalosporin derivative; making antibiotic effective against antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococci aureus (MRSA) |
| 01/19/2010 | US7648957 Comprising a peptide fraction which is preferably rich in di- and tripeptides in combination with an insulin sensitizer, preferably a natural or pharmaceutical insulin sensitizer; suitable as pharmaceutical or food or a food supplement; especially useful for Type 2 diabetes |
| 01/19/2010 | US7648695 A halogenated xanthene derivative, preferably Rose Bengal; can be delivered at high concentrations to certain tissues |
| 01/19/2010 | CA2345329C Integrated radiation shield |
| 01/14/2010 | WO2010005697A2 18f-labelled three-and four-carbon acids for pet imaging |
| 01/14/2010 | WO2010004536A2 Medical imaging procedures and method and system for managing medical imaging procedures |
| 01/14/2010 | WO2010004512A2 Dicabba-analogues of octreotide |
| 01/14/2010 | WO2009143023A3 Neoplasia targeting peptides and methods of using the same |
| 01/14/2010 | WO2009140754A8 An anti-cancer cytotoxic monoclonal antibody |
| 01/14/2010 | WO2009110939A3 Drug delivery system for pharmaceuticals and radiation |
| 01/14/2010 | WO2009058851A3 Methods for diagnosing and monitoring treatment of lewy body dementia by assessing dopamine transporter level |
| 01/14/2010 | WO2009056837A3 Materials and methods for medical imaging |
| 01/14/2010 | US20100008861 Metal sulfide quantum dots which photoluminesce when excited by radiation capped with thiol-containing charged molecules in a single step; QDs ready for surface immobilization of antibodies and other biomolecules |
| 01/14/2010 | US20100008856 Tracers for monitoring the activity of sodium/glucose cotransporters in health and disease |
| 01/14/2010 | US20100008855 Production and Use of Novel Peptide-Based Agents with Bispecific Antibodies |
| 01/14/2010 | US20100008853 Anti ganglioside gd3 antibodies and uses thereof |
| 01/14/2010 | US20100008852 Bi-specific monoclonal antibody (specific for both cd3 and cd11b) therapeutic drug |
| 01/14/2010 | US20100008851 Anti-gd2 antibodies and methods and uses related thereto |
| 01/14/2010 | CA2730270A1 Dicarba-analogues of octreotide |
| 01/14/2010 | CA2729949A1 Prostaglandin e2 dual variable domain immunoglobulins and uses thereof |
| 01/14/2010 | CA2728343A1 18f-labelled three- and four-carbon acids for pet imaging |
| 01/13/2010 | EP2142927A1 A nanoporous particle with a retained target |
| 01/13/2010 | EP2142567A2 The ed-a antigen of fibrinogen is associated with the neovasculature of tumour metastases |
| 01/13/2010 | EP2142284A2 Method and apparatus for isolating 186rhenium |
| 01/13/2010 | CN100579959C Method for preparing adamantane disulfide dinitride derivative |
| 01/12/2010 | US7645891 E.g., 4-(2-methyl-3-oxo-hept-6-en-2-yl)-2,2-dimethyl-[1,3]-dioxane chemical intermediate; chemical/metabolic stabilization of microtubuli; antitumor, -carcinogenic agents; malignant melanoma, acute lymphocytic/myelocytic leukemia; angiogenesis inhibitors; antiinflammatory/-arthritic agents; psoriasis |
| 01/12/2010 | CA2346170C Site-specific labeling of disulfide-containing targeting vectors |
| 01/07/2010 | WO2010000714A2 Radioimmunoconjugate kit |
| 01/07/2010 | WO2009135015A3 Improved methods and compositions for f-18 labeling of proteins, peptides and other molecules |
| 01/07/2010 | WO2009128610A3 Cell labeling and imaging using multifunctional perfluorocarbon nanoemulsion |
| 01/07/2010 | US20100004276 Vitamin receptor binding drug delivery conjugates |
| 01/07/2010 | US20100004241 Non-imidazole aryloxyalkylamines |
| 01/07/2010 | US20100003252 Blocking immune response to a graft |
| 01/07/2010 | US20100003195 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| 01/07/2010 | US20100003192 Treatment of breast cancer with a parp inhibitor alone or in combination with anti-tumor agents |
| 01/07/2010 | US20100003191 Aurone derivative-containing composition for diagnosis |
| 01/07/2010 | US20100003190 Method for protecting renal tubular epithelial cells from radiocontrast nephropathy (RCN) |
| 01/07/2010 | US20100003189 Cancer biomarkers and methods of use thereof |
| 01/06/2010 | EP2139848A1 Deuterium labelled ketamine |
| 01/06/2010 | CN100577728C Finely particulate composite containing carbon compound encapsulated therein |
| 01/06/2010 | CN100577213C Non-invasive diagnostic imaging technology for mitochondria dysfunction using radiolabeled lipophilic salts |
| 01/05/2010 | US7642342 Generate immune response by activation of a T cell or a B cell to claimed peptide, nucleotide expressed in a viral vector; vaccinia, fowlpox, canarypox, adenovirus, influenza, poliovirus, adeno-associated virus, lentivirus, Sindbis virus; diagnostic and therapeutic applications |
| 01/05/2010 | US7642232 Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
| 01/05/2010 | US7642063 Methods for targeting and killing glioma cells |
| 01/05/2010 | US7641901 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 01/05/2010 | US7641891 Chimeric, human and humanized anti-CSAp monoclonal antibodies |
| 01/05/2010 | US7641823 Synthesis of small particles |
| 01/05/2010 | CA2438902C Manufacturing process to control particle size |
| 12/31/2009 | US20090324592 Compositions and methods for the diagnosis and treatment of tumor |
| 12/31/2009 | US20090324499 Vitamin-targeted imaging agents |
| 12/31/2009 | US20090324497 Tc and Re Labeled Radioactive Glycosylated Octreotide Derivatives |
| 12/31/2009 | US20090324496 Radioactive material for inhibiting cancer and preparation method thereof |
| 12/31/2009 | US20090324495 Compounds and methods for enzyme-mediated tumor imaging and therapy |
| 12/31/2009 | US20090324494 Magnetic nano-composite for contrast agent, intelligent contrast agent, drug delivery agent for simultaneous diagnosis and treatment, and separation agent for target substance |
| 12/31/2009 | US20090324493 Method for preparing a saline solution comprising [13n] nh4 + and use of a device |
| 12/31/2009 | US20090324492 Treatment for Central Nervous System Disorders |
| 12/31/2009 | US20090324491 Diagnosis and Treatment of Cancer Using Anti-EREG Antibody |
| 12/31/2009 | US20090324490 Compositions and methods for the diagnosis and treatment of tumor |
| 12/31/2009 | US20090324489 Wortmannin conjugates and uses thereof |
| 12/30/2009 | WO2009156456A1 Muteins of hngal and related proteins with affinity for a given target |
| 12/30/2009 | WO2009155662A1 A tumour suppressor protein, caspase-2 |
| 12/30/2009 | WO2008119036A3 Compositions for targeted imaging and therapy |
| 12/30/2009 | EP1202973B1 Preparation of compounds useful for the detection of hypoxia |
| 12/30/2009 | CN101616695A Weakly basic 2- nitroimidazoles for the non-invasive detection of tissue hypoxia |
| 12/30/2009 | CN101612409A Targeting Claudin-4 imaging agent capable of regulating permeability among epithelial cells |
| 12/30/2009 | CN100574803C Use of immunoregulation antibody for the treatment of neoplastic disorders |
| 12/29/2009 | US7638598 ErbB interface peptidomimetics and methods of use thereof |
| 12/29/2009 | US7638283 Amyloid β protein (globular assembly and uses thereof) |
| 12/29/2009 | CA2189848C Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 12/24/2009 | US20090317903 Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors |
| 12/24/2009 | US20090317328 Tricyclic oxazepines as in vivo imaging compounds |
| 12/24/2009 | US20090317327 Aqueous Dispersion of Superparamagnetic Single-Domain Particles, Production and Use Thereof in Diagnosis and Therapy |
| 12/24/2009 | US20090317326 Radiofluorination methods |
| 12/24/2009 | US20090317325 Diagnostic Substance and Method for the Analysis of Metabolism Processes in the Brain |
| 12/24/2009 | US20090317324 Filamentous bacteriophage displaying protein as a binder of antibodies and immunocomplexes for delivery to the brain |
| 12/23/2009 | WO2009071444A3 Imaging method |